Disease Info Card

Platelet Storage Pool Deficiency

Information about Platelet Storage Pool Deficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Platelet Storage Pool Deficiency

Most recent studies have shown that Platelet Storage Pool Deficiency shares some biological mechanisms with albinism, albinism-oculocutaneous, bernard-soulier-syndrome, bleeding-tendency, blood-coagulation-disorders, blood-platelet-disorders, chediak-higashi-syndrome, colitis, fibrosis, gray-platelet-syndrome, hemorrhage, hemorrhagic-disorders, hermanski-pudlak-syndrome, hypopigmentation-disorder, leukemia, myeloproliferative-disease, pulmonary-fibrosis, thrombasthenia, tissue-adhesions, von-willebrand-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Platelet Storage Pool Deficiency, and have been seen in publications frequently: Adp Transport, Blood Coagulation, Chemotaxis, Coagulation, Endosomal Transport, Hemostasis, Inflammatory Response, Localization, Membrane Fusion, Pathogenesis, Pigmentation, Platelet Activation, Platelet Aggregation, Platelet Formation, Programmed Cell Death, Protein Phosphorylation, Secretion, Secretion Of Lysosomal Enzymes, Serotonin Uptake, Transport

Quite a number of genes have been found to play important roles in Platelet Storage Pool Deficiency, such as AP3B1, BLOC1S6, CD63, CFH, EPO, F2, FH, HOXD13, HPS1, LDLR, LYST, NOD2, PF4, PLEKHM1, PPBP, SELP, VWF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.